Skip to main content
Chimera S&P UAE UCITS ETF - Share Class A - Accumulating logo

Chimera S&P UAE UCITS ETF - Share Class A - Accumulating — Investor Relations & Filings

Ticker · CHAE ISIN · IE00BKDMN692 Dubai Financial Market Financial and insurance activities
Open in API
Filings indexed 207 across all filing types
Latest filing 2021-12-20 Regulatory Filings
Country AE United Arab Emirates
Listing Dubai Financial Market CHAE

About Chimera S&P UAE UCITS ETF - Share Class A - Accumulating

https://www.Lunate.com

Chimera S&P UAE UCITS ETF - Share Class A - Accumulating is a Shariah compliant exchange traded fund (ETF) that aims to provide investment returns, before fees and other costs, closely corresponding to the performance of the S&P UAE Broad Market Index. This ETF offers investors exposure to large-capitalization stocks and reinvests all dividends received, contributing to a total return strategy.

Recent filings

Filing Released Lang Actions
تنويه من الشركة
Regulatory Filings Classification · 95% confidence The document is a notification about the quarterly rebalancing of the S&P UAE BMI Liquid 20/35 Capped Index, detailing securities added and removed from the index. It is a regulatory or market update related to index composition changes rather than a financial report, earnings release, or management discussion. The document length is short (2605 characters) and it serves as an announcement rather than a detailed report. There is no indication of financial statements, management commentary, or audit information. This fits best under Regulatory Filings (RNS) as a general regulatory announcement or compliance update.
2021-12-20 Arabic
Notification from the company
Regulatory Filings Classification · 95% confidence The document is a notification about the quarterly rebalancing of the S&P UAE BMI Liquid 20/35 Capped Index, detailing securities added and removed from the index. It is dated December 20, 2021, and is addressed to the CEO of Dubai Financial Market. The content is a regulatory announcement related to index composition changes rather than a financial report, earnings release, or management discussion. The document length is short (2605 characters) and primarily serves as an update or notice. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not contain financial statements or detailed analysis.
2021-12-20 English
أداء الصندوق لشهر نوفمبر٢٠٢١
Fund Information / Factsheet Classification · 100% confidence The document is titled 'Chimera S&P UAE UCITS ETF - Accumulating November 2021 Factsheet' and contains detailed information about the fund's overview, performance, key facts, sectors, top holdings, and disclaimers. It provides a brief summary of key company facts, financials, and market information related to the ETF. The document is concise and formatted as a factsheet rather than a comprehensive report or regulatory filing. There is no indication of it being an annual or interim report, audit report, or any other detailed regulatory filing. Therefore, it fits the definition of a Fund Information / Factsheet (FS).
2021-12-05 Arabic
Fund performance for the month of November 2021
Fund Information / Factsheet Classification · 95% confidence The document is titled 'Chimera S&P UAE UCITS ETF - Accumulating November 2021 Factsheet' and contains detailed information about the fund's overview, performance, key facts, sectors, top holdings, and disclaimers. It provides a concise summary of the fund's characteristics, performance metrics, and investment details. The document is brief and formatted as a summary sheet rather than a comprehensive report or regulatory filing. There is no indication of it being an annual or interim report, audit, earnings release, or any other detailed financial report. The content matches the description of a Fund Information / Factsheet, which is typically a brief summary of key company facts, financials, and market info for an investment fund.
2021-12-05 English
تنويه من الشركة
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the CEO of Dubai Financial Market regarding an update to the Prospectus of Chimera UCITS ICAV. It mentions approval by the Central Bank of Ireland for changes to the Prospectus and Supplement, and provides details about clarifications to the investment policy, definitions of Tracking Difference and Tracking Error, and the effective date of these changes. The document also informs shareholders about the opportunity to redeem shares before the changes take effect. The content is focused on notifying about changes to the Prospectus and providing updated disclosure information rather than presenting the full updated Prospectus itself. The document length is 7218 characters, which is relatively short and consistent with an announcement or notification rather than a full report. The document states that the updated Prospectus and Supplement will be available on the website, indicating this is an announcement of the update rather than the full report. Therefore, this document fits best as a Regulatory Filing (RNS) because it is a formal notification about regulatory approval and changes, not the full Prospectus or a detailed financial report.
2021-11-25 Arabic
Notification from the company
Regulatory Filings Classification · 95% confidence The document is a letter dated November 2021 from Chimera Capital Limited to the Dubai Financial Market CEO regarding an update to the Prospectus of Chimera UCITS ICAV. It informs about the Central Bank of Ireland's approval of changes to the Prospectus and Supplement, and provides details on clarifications to the investment policy, definitions of Tracking Difference and Tracking Error, and the effective date of these changes. The document also mentions shareholders' rights to redeem shares before the changes take effect. The content is focused on notifying regulatory approval and changes to the fund's prospectus rather than presenting the full updated prospectus or detailed financial statements. The document is about the announcement of a prospectus update, not the prospectus report itself. It is a regulatory announcement informing the market and shareholders of the update and availability of the revised prospectus. Therefore, it fits best as a Regulatory Filing (RNS) rather than a full report like Annual Report or Fund Information or Proxy Solicitation.
2021-11-25 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.